Research programme: asthma therapeutics - Synairgen
Alternative Names: IL-13 inhibitors; IL-4 inhibitorsLatest Information Update: 19 Mar 2014
At a glance
- Originator Synairgen
- Class Peptides
- Mechanism of Action Interleukin 13 inhibitors; Interleukin 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 19 Mar 2014 Discontinued for Asthma in United Kingdom (unspecified route)
- 14 Dec 2006 Early research in Asthma in United Kingdom (unspecified route)